Heads we win, tails you lose

First Distillers Co and now Roche. It is an almost perverse element that links these seemingly‐unrelated controversies. Indeed, if the Swiss‐owned drugs company is looking for tangible justification for pricing two of its products so highly, it need look no further than the Thalidomide tragedy.